SciCombinator

Discover the most talked about and latest scientific content & concepts.

Abstract
A multitarget stool DNA (mt-sDNA) test was recently approved for colorectal cancer (CRC) screening for men and women, aged ≥ 50 years, at average risk of CRC. The guidelines currently recommend a 3-year interval for mt-sDNA testing in the absence of empirical data. We used clinical effectiveness modeling to project decreases in CRC incidence and related mortality associated with mt-sDNA screening to help inform interval setting.
Tweets*
7
Facebook likes*
0
Reddit*
0
News coverage*
8
Blogs*
0
SC clicks
0
Concepts
Interval finite element, Clinical trial, Effectiveness, Order theory, Colorectal cancer, Epidemiology, Cancer, Medical statistics
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com